Sai Life Sciences Limited (NSE:SAILIFE)
India · Delayed Price · Currency is INR 875.90
+8.40 (0.97%)
At close: Dec 5, 2025
Sai Life Sciences Revenue
Sai Life Sciences had revenue of 5.37B INR in the quarter ending September 30, 2025, with 35.88% growth. This brings the company's revenue in the last twelve months to 20.53B, up 37.05% year-over-year. In the fiscal year ending March 31, 2025, Sai Life Sciences had annual revenue of 16.95B with 15.66% growth.
Revenue (ttm)
20.53B
Revenue Growth
+37.05%
P/S Ratio
8.97
Revenue / Employee
6.04M
Employees
3,401
Market Cap
184.09B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 16.95B | 2.29B | 15.66% |
| Mar 31, 2024 | 14.65B | 2.48B | 20.38% |
| Mar 31, 2023 | 12.17B | 3.48B | 39.97% |
| Mar 31, 2022 | 8.70B | 1.10B | 14.44% |
| Mar 31, 2021 | 7.60B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 549.64B |
| Aurobindo Pharma | 325.14B |
| Cipla | 279.66B |
| Zydus Lifesciences | 244.94B |
| Apollo Hospitals Enterprise | 232.65B |
| Glenmark Pharmaceuticals | 159.97B |
| Alkem Laboratories | 138.90B |
| Mankind Pharma | 135.46B |